Evaluation of Measles Immunity in Patients With Covid-19 Infection in Isfahan Publisher



M Pourahmad MORTEZA ; S Nasirharandi SARA ; M Momenzadeh MAHNAZ ; E Nasri ELAHE ; S Baradaran SHAHZAD ; K Shahzamani KIANA ; F Nikoukar FATEMEH ; Z Doozandeh ZAHRA ; A Arab Chadegani AMENEH
Source: Journal of Preventive Epidemiology Published:2025

Abstract

Introduction: COVID-19 has become a widespread epidemic worldwide. The different vaccines may play a protective effect on illness intensity. Therefore, in this study, we aimed to evaluate measles IgG titer in COVID-19 patients and correlate it with disease severity. Objectives: We evaluated the measles IgG titer and intensity of illness with measles-specific immunoglobulin G (IgG) in COVID-19 patients. Patients and Methods: This cross-sectional study was conducted on 72 patients infected with COVID-19 with high and low severity. An enzyme-linked immunosorbent assay (ELISA) was used to detect the measles-mumps-rubella (MMR) vaccine’s serum IgG antibody in COVID-19 patients. Then, the correlation of disease intensity and IgG level was evaluated using one-way analysis variance (ANOVA) in SPSS 26. Results: In this study, there was a significant difference between illness intensity and IgG serum level of MMR in experimental groups (P < 0.05). Conclusion: There is a significant relationship between the severity of COVID-19 and measles IgG titer. © 2025 Elsevier B.V., All rights reserved.